HLK Biotech Holding Group, Inc. (AMHD)

HLK Biotech Holding Group Income Statement

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	FY 1999	FY 1998
Period Ending	Jun 30, 1999	Jun 30, 1998
Cost of Revenue	0.18	-
Gross Profit	-0.18	-
Selling, General & Admin	0.52	0.96
Operating Expenses	0.53	0.96
Operating Income	-0.71	-0.96
Interest Expense	-0.01	-
Interest & Investment Income	0.01	-
EBT Excluding Unusual Items	-0.72	-0.96
Other Unusual Items	-0.32	-
Pretax Income	-1.04	-0.96
Net Income	-1.04	-0.96
Net Income to Common	-1.04	-0.96
EBITDA	-0.7	-
D&A For EBITDA	0.01	-
EBIT	-0.71	-0.96

Source: S&P Global Market Intelligence. Standard template. Financial Sources.